Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1996
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032408A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
10/17/1996WO1996032387A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
10/17/1996WO1996032386A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/17/1996WO1996032384A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/17/1996WO1996032382A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996WO1996032380A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
10/17/1996WO1996032376A1 Novel borneol esters, process for their preparation and their pharmaceutical use
10/17/1996WO1996032115A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996WO1996032111A1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
10/17/1996WO1996032107A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
10/17/1996WO1996032105A1 Lactacystin analogs
10/17/1996WO1996032104A1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
10/17/1996WO1996032103A1 A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
10/17/1996WO1996032101A1 Cancerous metastasis inhibitor
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases
10/17/1996DE19512484A1 Kohlenhydratmodifizierte Cytostatika Carbohydrate-modified cytostatics
10/17/1996CA2220827A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996CA2217955A1 A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
10/17/1996CA2217951A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996CA2217817A1 Lactacystin analogs
10/17/1996CA2216858A1 Phospholipase c homolog
10/17/1996CA2216655A1 New borneol esters, process for their production, and their pharmaceutical use
10/17/1996CA2212356A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737311A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases
10/16/1996EP0737251A1 Antibodies to egf receptor and their antitumour effect
10/16/1996EP0737248A1 Gene expression control
10/16/1996EP0737200A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
10/16/1996EP0737199A1 Method for preparing concentrated biologically active silicon compounds
10/16/1996EP0737190A1 [4-(1,2-epoxycyclohexanyl) but-3-en-1-ynyl] aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
10/16/1996EP0737070A1 Vitamin d 3? analogues and pathway to mediate disorders
10/16/1996EP0737067A1 Method of treatment of hormone-unresponsive metastatic prostate cancer
10/16/1996EP0648254B1 Luminescent article with high phosphor to binder ratio and manufacture thereof
10/16/1996EP0610179B1 Target specific antibody-superantigen conjugates and their preparation
10/16/1996EP0571546B1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133595A Mutants of the Rb and P53 genes and uses thereof
10/16/1996CN1133559A photosensibilizers
10/16/1996CN1133293A Platinum matches and medicine for malignant tumor containing said platinum matches
10/16/1996CN1033029C Prepn. of indenoindole compound
10/15/1996US5565494 Benzenesulfonylurea derivatives
10/15/1996US5565491 Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
10/15/1996US5565424 Vasoactive intestinal peptide antagonists useful as antitumor and anticancer agents
10/15/1996CA1338645C Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins"
10/10/1996WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
10/10/1996WO1996031605A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996WO1996031601A1 Polynucleotide immunogenic agents
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031532A1 Sugar-modified cytostatics
10/10/1996WO1996031513A1 Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/10/1996WO1996031510A1 Pyrazole derivatives and processes for the preparation thereof
10/10/1996WO1996031501A1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
10/10/1996WO1996031493A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
10/10/1996WO1996031478A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/10/1996WO1996031477A1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
10/10/1996WO1996031452A1 9-substituted porphycenes
10/10/1996WO1996031451A1 9-substituted porphycenes
10/10/1996WO1996031237A2 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
10/10/1996WO1996031111A1 Tricyclic compounds useful in the treatment of cell proliferative disorders
10/10/1996WO1996021416A3 Methods and compositions for treatment of solid tumors in vivo
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996CA2217697A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996CA2217680A1 Tricyclic compounds useful in the treatment of cell proliferative disorders
10/10/1996CA2217491A1 Polynucleotide immunogenic agents
10/10/1996CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
10/10/1996CA2217213A1 9-substituted porphycenes
10/10/1996CA2217164A1 Sugar-modified cytostatics
10/10/1996CA2216654A1 Inhibitors of farnesyl-protein transferase
10/10/1996CA2215978A1 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
10/10/1996CA2214411A1 9-substituted porphycenes
10/09/1996EP0736543A2 Method for the production of monoclonal antibodies to proliferation-associated antigens of the cell nucleus
10/09/1996EP0736530A2 Retinoid-like heterocycles
10/09/1996EP0736299A1 Process for preparing a liposomal, water-dispersable, solid, dry, therapeutic formulation for oral administration
10/09/1996EP0736095A1 Human circulating cytokine cc-1
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736093A1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB PLAYS A ROLE
10/09/1996EP0736039A1 Compounds with growth hormone releasing properties
10/09/1996EP0736008A1 Indole derivatives as anti-estrogens
10/09/1996EP0736004A1 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735880A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation
10/09/1996EP0735876A1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin
10/09/1996EP0735819A1 New cryptophycins
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0594578B1 Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
10/09/1996EP0528820B1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
10/09/1996EP0513351B1 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient
10/09/1996EP0354921B1 Use of melatonin for the manufacture of a contraceptive composition
10/09/1996CN1133064A GRB3-3 gene, variants and uses thereof
10/09/1996CN1133049A Melanona-inhibiting protein
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1133007A Di- and tetra-hydrobenzo|F¨ quinolin-3-ones
10/09/1996CN1132745A Substituted henzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
10/08/1996US5563286 Elimination of 4-protected hydroxy group in presence of hydrogen radical source and a free radical initiator
10/08/1996US5563268 Heterobiaryl derivatives
10/08/1996US5563255 Antisense oligonucleotide modulation of raf gene expression
10/08/1996US5563163 Treatment of degenerative diseases
1 ... 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 ... 2211